促甲状腺激素与2型糖尿病血管并发症的相关性研究  

Research Progress on the Relationship Between Thyroid Stimulating Hormone and Vascular Complications ofType 2 Diabetes Mellitus

作　　者：李金金[1] 张秋梅[1] LI Jinjin;ZHANG Qiumei(Tianjin Medical University Chu Hsien-I Memorial Hospital,Tianjin 300134,China)

机构地区：[1]天津医科大学朱宪彝纪念医院,天津300134

出　　处：《现代诊断与治疗》2022年第3期347-349,共3页Modern Diagnosis and Treatment

摘　　要：2型糖尿病血管并发症是导致患者死亡的主要因素,长期血糖增高损害微血管、大血管,并波及心脏、脑、肾、周围神经组织等,已有大量研究表明2型糖尿病血管并发症发生与血压、血脂、肾病等因素有关。近年来,临床对糖尿病患者甲状腺功能异常会增加血管并发症的发生存在较大的争议。对此,文章总结近年来关于甲状腺功能与糖尿病血管并发症的相关性研究,就促甲状腺激素对2型糖尿病血管并发症的作用机制、相关性流行病学进行分析,为临床评估和治疗2型糖尿病血管并发症提供依据。Vascular complications of type 2 diabetes mellitus are the main factors leading to the death of patients.Long term hyperglycemiacan damage microvessels and major vessels,and affects the heart,brain,kidney and peripheral nerve tissues.A large number of studies have shown that the occurrence of vascular complications of type 2 diabetes is related to blood pressure,blood lipid,nephropathy and other factors.In recent years,whetherthyroid dysfunction in patients with diabetes will increase the occurrence of vascular complications is under controversy in clinic.In this regard,this paper summarizes the recent studies on the correlation between thyroid function and diabetic vascular complications,and analyzes the mechanism and epidemiology of thyroid stimulating hormone on vascular complications of type 2 diabetes,so as to provide evidence for clinical evaluation and treatment of type 2 diabetic vascular complications.

关 键 词：促甲状腺激素 2型糖尿病 血管并发症 甲状腺功能 

分 类 号：R587.2[医药卫生—内分泌] R446.1[医药卫生—内科学]